Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 73 (4), 933-8

Effects of Cyclic AMP- And Cyclic GMP- Phosphodiesterase Inhibitors on Immunological Release of Histamine and on Lung Contraction

Effects of Cyclic AMP- And Cyclic GMP- Phosphodiesterase Inhibitors on Immunological Release of Histamine and on Lung Contraction

N Frossard et al. Br J Pharmacol.

Abstract

1 Cyclic adenosine 3',5'-monophosphate (cyclic AMP)- and cyclic guanosine 3',5'-monophosphate (cyclic GMP)-phosphodiesterase activities from rat lung were selectively inhibited by ZK 62711 and M & B 22948, respectively. Theophylline and papaverine inhibited both activities. 2 Rat lung strips contracted by carbachol were relaxed by 4-(3-cyclopentyloxy-4-methoxyphenyl)-2-pyrrolidone (ZK 26711, EC25 = 7 x 10(-8)M) and 2-O-propoxyphenyl-8-azapurin-6-one (M & B 22948, EC25 = 5 x 10(-7)M) indicating relaxant properties of both cyclic AMP and cyclic GMP. 3 The antigen-induced histamine release from human basophils was inhibited by ZK 62711 (IC25 = 8 x 10(-7)M), whereas M & B 22948 had no effect. On the contrary, the release from rat mast cells was inhibited by M & B 22948 (IC25 = 10(-6)M), while ZK 62711 had no effect. 4 These data show an inhibitory effect of cyclic AMP on histamine release to be involved with basophils, whereas cyclic GMP is predominantly involved with mast cells. Is is suggested that the antianaphylactic properties of cyclic nucleotide phosphodiesterase inhibitors are mainly linked to the increase of cyclic GMP.

Similar articles

See all similar articles

Cited by 11 PubMed Central articles

See all "Cited by" articles

References

    1. Science. 1968 Aug 30;161(3844):902-3 - PubMed
    1. Nature. 1969 Dec 6;224(5223):1028-9 - PubMed
    1. Int Arch Allergy Appl Immunol. 1970;38(1):68-77 - PubMed
    1. J Immunol. 1971 May;106(5):1267-73 - PubMed
    1. Fed Proc. 1971 Nov-Dec;30(6):1725-9 - PubMed

Publication types

MeSH terms

LinkOut - more resources

Feedback